Earnings Call to discuss the Unaudited Financial Results of the Company for the quarter ended June 30, 2026

July 24, 2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, Bandra-Kurla Complex, Phiroze Jeejeebhoy Towers, Bandra (E), Mumbai - 400 051. Dalal Street, Mumbai – 400 001. Symbol: STAR Scrip Code: 532531 Dear Madam/ Sir, Sub: Earnings Call to discuss the Unaudited Financial Results of the Company for the quarter ended June 30, 2026. This is to inform you that Company has scheduled an Earnings Call for investors/ analysts to discuss its Unaudited Financial Results for the quarter ended June 30, 2026, as per the following details: Day and Date Time Meeting Type Scheduled for Friday, 17:00 Hrs (IST) Conference Call – Investors/ July 31, 2026 Group Meet Analyst Group Invitation for the said Earnings Call is enclosed for your information and records. Above information will also be made available on the Company’s website at www.strides.com. Thanks & Regards For Strides Pharma Science Limited, Manjula Ramamurthy Company Secretary & Compliance Officer ICSI Membership No. A30515 Encl: a/a Strides Pharma Science Limited CIN: L24230MH1990PLC057062 Corp. Off: Strides House, Bilekahalli, Bannerghatta Road, Bengaluru – 560 076, India |Tel: +91 80 6784 0000 Regd. Off: ‘Cyber One’, Unit No. 902, Plot No. 4&6, Sector 30A, Vashi, Navi Mumbai – 400 703, India | Tel: +91 22 2789 2924/3199 corpcomm@strides.com; www.strides.com